News

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...
Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...
By Ludwig Burger FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more ...
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
We recently published a list of the 20 Best Dividend Growth Stocks with High Yields. In this article, we are going to take a ...
According to Merck, the total investment is now expected to be over $1 billion, with 500 full-time jobs and 4,000 ...
Shares of Merck & Co. Inc. MRK slid 1.86% to $77.65 Thursday, on what proved to be an all-around positive trading session for ...
We recently published a list of Billionaire Mario Gabelli’s 10 Large-Cap Stock Picks with Huge Upside Potential. In this ...
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for ...
As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...
RAHWAY, N.J. – Merck & Co., Inc., a global healthcare leader, announced positive results from its Phase 3 KEYNOTE-B96 trial, which could potentially lead to a new treatment option for patients ...